Joseph K. Belanoff
Overview
Joseph K. Belanoff received an average of $3M in total compensation, including $572K in salary, at Corcept Therapeutics from 2006 to 2021.
2021Corcept TherapeuticsChief Executive Officer and President
2020Corcept TherapeuticsChief Executive Officer and President
2019Corcept TherapeuticsChief Executive Officer and President
2018Corcept TherapeuticsChief Executive Officer and President
2017Corcept TherapeuticsChief Executive Officer and President
2016Corcept TherapeuticsChief Executive Officer and President
2015Corcept TherapeuticsChief Executive Officer and President
2014Corcept TherapeuticsChief Executive Officer and President
2013Corcept TherapeuticsChief Executive Officer and President
2012Corcept TherapeuticsChief Executive Officer and President
Source: SEC filings on April 25, 2022, April 22, 2021, April 27, 2020, April 24, 2019, April 24, 2018, April 21, 2017, April 22, 2016, April 20, 2015, April 7, 2014, May 17, 2010, and May 6, 2009.
Related executives
We found 12 more executives who work or worked at Corcept Therapeutics.
Atabak Mokari
Corcept Therapeutics
Chief Financial Officer
Charles Robb
Corcept Therapeutics
Secretary
Sean Maduck
Corcept Therapeutics
Chief Commercial Officer
Hazel Hunt
Corcept Therapeutics
Chief Scientific Officer
Andreas Grauer
Corcept Therapeutics
Chief Medical Officer
G Robb
Corcept Therapeutics
Chief Financial Officer
Robert Fishman
Corcept Therapeutics
Chief Medical Officer
Steven Lo
Corcept Therapeutics
Former Senior Vice President, Oncology
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019